International Biotechnology Trust PLC Infla Rx N.V. Transaction History

International Biotechnology Trust PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 18, 2020	SELL	$2.65 - $6.08 $583,000 - $1.34 Million	-220,000 Closed	0 $0
Q4 2019 May 18, 2020	BUY	$2.2 - $4.54 $484,000 - $998,800	220,000 New	220,000 $869,000
Q2 2019 Aug 14, 2019	SELL	$3.06 - $51.61 $99,450 - $1.68 Million	-32,500 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$31.16 - $48.62 $1.01 Million - $1.58 Million	32,500 New	32,500 $1.22 Million

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $72.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.